Top Markets
Coin of the day
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Kedudukan dalam Saham #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Harga Saham
$0.04895618
Disegerakkan terakhir: 2025-03-18
Modal Pasaran
$5.55M
Perubahan (1 hari)
-0.04%
Perubahan (1 tahun)
0.00%
Negara
CA
Perdagangan WPD Pharmaceuticals Inc. (WBIO)

Kategori

Nisbah P/B bagi WPD Pharmaceuticals Inc. (WBIO)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini WPD Pharmaceuticals Inc., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk WPD Pharmaceuticals Inc. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE